Business● Low1h ago · Nov 6, 2026, 1:56 AM
Halozyme expects $1.86B-$1.925B 2026 revenue while raising non-GAAP EPS to $8.75-$9.05
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Halozyme anticipates its 2026 revenue to be between $1.86 billion and $1.925 billion, and has increased its non-GAAP earnings per share projection to a range of $8.75 to $9.05. This indicates updated positive financial forecasts for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business25m agoTexas Roadhouse expects about 35 company-owned openings in 2027 as it raises 2026 capex to about $440MSeeking Alpha TechBusiness29m agoMSRTC announces ₹10,000 ex-gratia grant for 83,000 officersThe HinduBusiness34m agoGEO forecasts Q4 2026 revenue $777M-$827M with adjusted EBITDA $149M-$154M as ICE activations expandSeeking Alpha TechBusiness34m agoNorthwest Natural raises 2026 EPS guidance to $3.10-$3.20 as SiEnergy rate settlement and cost controls support outlookSeeking Alpha Tech